Navigation Links
Agrivida Announces Dan Meagher as Chief Executive Officer
Date:11/18/2013

MEDFORD, Mass., Nov. 18, 2013 /PRNewswire/ -- Agrivida, Inc., a biotechnology company developing technologies for animal nutrition, cellulosic sugars from biomass, and regulated enzymes, announced today the appointment of Dan Meagher as Chief Executive Officer. Mr. Meagher joins Agrivida from Novus International, where he was President of Global Animal Nutrition Solutions and responsible for global sales, marketing, animal R&D, business development, customer service, logistics & distribution and local manufacturing blend facilities.  Prior to Novus, Dan was President of the Egg Products Further Processing Business Unit at MOARK, LLC, a producer and marketer of shell eggs and egg products, COO & Executive Vice President at MBA Poultry LLC, and Vice President at Purina Mills. "I'm extremely excited to be joining Agrivida, whose technology represents a paradigm shift in delivering performance to the animal nutrition industry at the lowest cost possible," stated Mr. Meagher.

Dan takes over at Agrivida as Mark Wong is named to Chairman of Agrivida's Board of Directors.  "We are extremely fortunate to have Dan Meagher joining Agrivida to lead our team into this next phase of development," said Mr. Wong. "Dan's experience in the animal nutrition area will be critical to driving the commercialization of Agrivida's technology in several areas." Mr. Wong assumes the chairman position following five years of service as Agrivida's CEO. During his tenure, Mr. Wong led the company through several successful rounds of financing and established strategic relationships with corn seed and biofuels companies.

Agrivida's new leadership team represents a broadening of the company's expertise, reflecting its growing pipeline of biotechnology products for the animal nutrition, biofuels, and industrial enzyme markets. 

About Agrivida, Inc.

Agrivida is developing and commercializing high-performance products that incorporate novel, regulated proteins precisely engineered for specific applications in a variety of markets, including animal feed and nutrition, bio-based fuels and chemicals, and industrial enzymes. Agrivida is transforming the economics of industrial and agricultural production through our pioneering use of regulated enzymes to develop higher-efficiency, lower-cost biomass feedstocks and intermediate inputs.


'/>"/>
SOURCE Agrivida, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. POET And Agrivida Sign Technology Collaboration Joint Development Agreement
2. QIAGEN Announces Third Co-Development Program for Companion Diagnostics Paired With Lillys Investigational Cancer Compounds
3. Sangamo BioSciences Announces Presentation Of Clinical Data From Alzheimers Disease Program
4. Vet-Stem, Inc. Proudly Announces Distribution Agreement with Animal Health International, Inc. for Regenerative Cell Therapies
5. Ceres Announces Webcast of Fiscal Year 2013 Financial Results
6. Anterios, Inc., Announces Results of Consumer Survey Revealing Widespread Problem of Excessive Sweating and Desire for New Topical Botulinum Toxin Treatment
7. Cord Blood America Announces 2013 Third Quarter Financial Results
8. IPISC announces IP insurance for the Biotechnology/Pharma Industry
9. Z Trim Holdings, Inc. Announces Pricing of Public Offering of Common Stock and Warrants
10. RXi Pharmaceuticals Announces the Start of Their First Phase 2 Study with RXI-109 for Treatment of Hypertrophic Scars in Conjunction with Scar Revision Surgery
11. LayerBio, Inc. Announces Launch; Signs Option for Technology from MIT
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... 2017 , ... Disappearing forests and increased emissions are the main causes of ... year. Especially those living in larger cities are affected by air pollution related diseases. ... most pollution-affected countries globally - decided to take action. , “I knew I had ...
(Date:10/11/2017)... ... October 11, 2017 , ... Singh Biotechnology today announced that ... SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of Transcription 3) B VHH13 ... cross the cell membrane and bind intracellular STAT3 and inhibit its function. Dysregulation ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give ... Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles ...
(Date:10/10/2017)... ... , ... Dr. Bob Harman, founder and CEO of VetStem Biopharma, Inc. ... The event entitled “Stem Cells and Their Regenerative Powers,” was held on August ... MPVM was joined by two human doctors: Peter B. Hanson, M.D., Chief of Orthopedic ...
Breaking Biology Technology:
(Date:4/13/2017)... 2017 According to a new market research report ... Identity Administration, and Authorization), Service, Authentication Type, Deployment Mode, Vertical, and Region ... expected to grow from USD 14.30 Billion in 2017 to USD 31.75 ... ... MarketsandMarkets Logo ...
(Date:4/11/2017)... 11, 2017 No two people are ... the New York University Tandon School of Engineering ... found that partial similarities between prints are common ... mobile phones and other electronic devices can be ... vulnerability lies in the fact that fingerprint-based authentication ...
(Date:4/5/2017)... 2017  The Allen Institute for Cell Science today ... one-of-a-kind portal and dynamic digital window into the human ... first application of deep learning to create predictive models ... and a growing suite of powerful tools. The Allen ... future publicly available resources created and shared by the ...
Breaking Biology News(10 mins):